MNSO(09896) has completed the issuance of equity-linked securities with a principal amount of 550 million US dollars.

date
14/01/2025
avatar
GMT Eight
MNSO(09896) announced that it has completed the issuance of stock-linked securities with a principal amount of 550 million US dollars.
pre
Shanghai Fosun Pharmaceutical (02196): "XH-S003" has initiated Phase II clinical trials in China for the treatment of complement abnormal activation related to IgA nephropathy and other glomerular diseases.
A-share announcement highlights | Great Wall Motor (601633.SH) expects net profit to increase by 77% to 85% in 2024.
next

RECOMMEND

recommend

US Stock Market Move | "Monster Hunter: Wilderness" drives PS5 weekly sales up seven times, Sony (SONY.US) stock rises over 3%"

date
12/03/2025
recommend

US Stock Market Move | The weight loss drug Cagrisema's clinical trial results did not meet expectations. Novo Nordisk A/S Sponsored ADR Class B (NVO.US) dropped more than 5%.

date
12/03/2025
recommend

Asiayang Group (01907) is planning an asset + cash transaction, and may take control of SINOHYTEC (688339.SH,02402) to expand its hydrogen industry chain layout.

date
12/03/2025

©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.

Contact: contact@gmteight.com